Clinical Trial Biorepository and Archiving Solutions Market - Databook 2025 to 2034

The global clinical trial biorepository and archiving solutions market size surpassed USD 4.66 billion in 2024 and is predicted to reach around USD 12.06 billion by 2034, registering a CAGR of 9.97% from 2025 to 2034.

Highlights of the Clinical Trial Biorepository and Archiving Solutions Market

• North America held a significant share of the clinical trial biorepository and archiving solutions market in 2024.
• Asia Pacific is projected to host the fastest-growing market in the coming years.
• By product, the clinical products segment underwent notable growth in the clinical trial biorepository and archiving solutions market during 2024.
• By product, the preclinical products segment will gain a significant share of the market over the studied period of 2025 to 2034.
• By phase, the phase III segment enjoyed a prominent position in the clinical trial biorepository and archiving solutions market during 2024.
• By phase, the phase II segment is predicted to witness significant growth in the market over the forecast period.
• By service, the biorepository service segment captured a significant portion of the clinical trial biorepository and archiving solutions market in 2024.
• By service, the archiving solutions segment is predicted to expand rapidly in the market in the coming years.

Industry Valuation and Growth Rate Projection

The clinical trial biorepository and archiving solutions in which biorepository is a facility that collects, catalogs, and stores samples of biological materials like protein, DNA, RNA, cells, tissue, blood, and urine from plants, humans, or animals for laboratory research and clinical trial archiving includes planning, implementing, and maintaining a repository of documents and electronic records containing clinical information, supporting documentation, and any interpretations from a clinical trial. Increasing investment in biobanking infrastructure, rising demand for long-term data storage and preservation, and growing demand for adhering to stringent regulations are driving the growth of the clinical trial biorepository and archiving solutions market.

• In February 2023, Surrozen selected its Trial Interactive eClinical platform, including electronic Trial Master File (eTMF) and TMF solutions, to create a centralized, quality-focused approach to TMF management was announced by a leading provider of services and technologies to support global clinical trials and product development for the pharmaceutical industry, TransPerfect Life Sciences.

Clinical Trial Biorepository and Archiving Solutions: Stats & Figures

• According to a report published by the World Health Organization (WHO) in December 2024, the number of trials listed in the WHO International Clinical Trials Registry Platform (ICTRP) is reported by year, country, WHO region, and income group for the period 1999- June 2024.

Number of Clinical Trials By Country or Area

How has AI Benefited the Clinical Trial Biorepository and Archiving Solutions Market?

AI streamlines clinical trials by improving protocol design, predicting outcomes, and analyzing big datasets. AI can aid participant recruitment by matching eligible patients to trials. AI can improve safety monitoring with real-time alerts for adverse events. AI can be used to stimulate data to detect more effective statistical outcome measures. AI helps clinical data managers by automating time-consuming, complex data management processes in medical coding, data reconciliation, and ATRs. Healthcare AI systems can analyze patterns in a patient’s medical history and current health data to predict potential health risks.

Industry Leader Announcements

• Dan Shine, senior vice president and president of analytical instruments, Thermo Fischer

Dan Shine, senior vice president and president of analytical instruments, Thermo Fischer, said, “At Thermo Fischer Scientific, we are revolutionizing the scientific landscape and delivering unprecedented insights that drive progress where our customers need it most.” “By combining higher performing instruments with technology that supports innovative, end-to-end workflows, we are helping researchers expedite discoveries that will impact human health, drug development, and environmental sustainability.”

• Alex Esmon, Vice President and General Manager of Global Products at Azenta Life Sciences

Alex Esmon, Vice President and General Manager of Global Products at Azenta Life Sciences, said, “We are excited to support UK Biocentre with the advanced automation sample storage capabilities of the BioArc Ultra.” “The addition of the BioArc Ultra delivers on the promise of enabling breakthroughs faster through substantial improvements in proven automation and refrigeration that ensure critical sample integrity while streamlining workflows and ensuring sustainability.”

Geographical Insights

North America held a significant share of the clinical trial biorepository and archiving solutions market in 2024. Rising investment in biobanking infrastructure, increasing demand for long-term data storage and preservation, rising demand for adhering to stringent regulations, and an increase in clinical trials are driving the growth of the market in the North American region.

Asia Pacific is projected to host the fastest-growing market in the coming years. Increasing adoption of advanced technologies, advancements in automation, supporting global research, and innovative healthcare solutions are driving the clinical trial biorepository and archiving solutions market in the Asia Pacific.

Recent Developments in the Clinical Trial Biorepository and Archiving Solutions Market:

• In July 2024, the One Health Innovation Lab within the newly rebranded Venture One Health building at Innovation Park was launched by The Innovation Foundation at Oklahoma State University. This innovative facility is set to advance the University’s One Health Initiative, driving research and collaboration at the intersection of human, animal, and environmental health.
• In June 2024, the opening of the new site in the Netherlands specializing in ambient to cryogenic storage, clinical and commercial packaging, labeling, and distribution, and clinical QP release services, ultra-cold facility in the EU, expanding its clinical trial network in Europe to help accelerate the development of advanced therapies was launched by the world leader in serving science, Thermo Fischer Scientific, Inc.

Competitive Landscape

• Company Name: Thermo Fischer Scientific Inc.
• Year of Incorporation: 1956
• Headquarters: Waltham, Massachusetts, United States

Over 50 countries where it operates. It operates in the clinical research and life science sectors around the world.

• Company Name: Azenta U.S.
• Year of Incorporation: 1978
• Headquarters: Chelmsford, Massachusetts, United States

It operates in several countries. It operates in the life science sectors around the world.